Bill > H0648

This bill establishes new provisions for health benefit plans in Idaho concerning anticancer medications, defining an "anticancer medication" as any drug or biologic used to combat cancer, regardless of how it's administered (oral, intravenous, or injection). Crucially, for health benefit plans issued or renewed on or after January 1, 2027, this bill mandates that the cost-sharing requirements, such as copayments, coinsurance, and deductibles, for orally administered anticancer medications must be the same as those for injected or intravenously administered anticancer medications. This aims to ensure equitable financial burdens for patients regardless of their cancer treatment's delivery method, while still allowing health plans to use tools like drug lists (formularies), prior authorization, or other controls to manage coverage. The bill also declares an emergency, making its provisions effective on July 1, 2026.

Business and Industry, Health and Social Services

Business Committee (House)

https://legislature.idaho.gov/sessioninfo/2026/legislation/H0648/